20.40
+0.3(+1.49%)
Currency In EUR
Sector
Technology
Industry
Hardware, Equipment & Parts
Employees
1027
First IPO Date
October 21, 2016
| Name | Title | Pay | Year Born |
| Mr. Jean-Marc Gendre | Deputy General Director & Chief Executive Officer of Lumibird Medical | 246,992 | N/A |
| Dr. Marc Le Flohic | Chief Executive Officer & Chairman | 554,630 | 1963 |
| Ms. Aude Nomblot-Gourhand | Financial Director | 0 | N/A |
| Mr. Alexandre Billard | Purchasing Director & Sales Director | 0 | N/A |
| Mr. Nicolas Ballif | Director of Human Resources | 0 | N/A |
| Mr. Nigel Holehouse | Program Director | 0 | N/A |
| Mr. Frederic Chiquet | Chief Corporate Social Responsibility Officer | 0 | N/A |
| Ms. Sonia Rutnam | Group Secretary General and Director of General Finance & Information Systems | 0 | N/A |
| Mr. Philippe Metivier | Director of Research & Development | 0 | 1961 |
| Mr. Pierre-Franasois Chenevier | Deputy General Director & General Director of Photonics Division | 0 | N/A |
Lumibird SA engages in the design, manufacturing and marketing of lasers. The company is headquartered in Lannion, Bretagne and currently employs 541 full-time employees. The firm offers a range of products, including compact pulsed Nd, double-pulse Nd, tunable laser systems, flash-lamp pumped lasers, diode-pumped solid-state lasers, semiconductor laser modules and intense pulsed light instruments, among others. Lumibird provides lasers to industrial and scientific clients, as well as the medical sector, among others. The firm operates worldwide through the subsidiaries, such as Quantel Medical, which specializes in the development and marketing of diagnostic ocular ultrasound systems and surgical lasers; Quantel USA, which designs and produces fiber lasers, glass laser systems and tunable lasers, and Quantel Derma AT, which focuses on the development, production and sales of the laser technology products in the areas of dermatology and aesthetics.